Pyc Therapeutics Ltd has released a press release.
Combination therapy escalates potency of Phylogica peptides
Filed with ASX ·
6ix hasn’t read this filing yet.
PYC Therapeutics Limited on 6ix
Story so far
Earlier from PYC Therapeutics
- US Patent Synthetic Phylomer Libraries
- US Patent granted
- Roche Collaboration Extended
- Response to ASX Query - Price Query
- Response to ASX price query
Later from PYC Therapeutics
- Entitlement Issue and Note Conversion
- New Patent to Discover Sophisticated Cell Penetrating Drugs
- Core patent granted in Australia
- European Patent Granted
- R&D tax offset refund
Follow PYC Therapeutics into a list and get an email when it puts out news.
Follow PYC Therapeutics